Sun Pharmaceutical Industries Limited reported consolidated net profit of Rs 1,984 crore for the quarter ended March 2021. The consolidated net sales stood at Rs 9,799 crore.
Consolidated EBITDA was Rs 3,027 crore for the quarter ended March 2021. The board recommended a dividend of Rs 1.50 per equity share of Re 1 each. For the full year ended 31 March 2021, the company reported a consolidated net profit of Rs 8,412 crore.